CALCbenzinga

Reported Earlier, CalciMedica Launches $10.2M Stock Offering Of 2.72M Shares At $3.75/Share to Advance Inflammatory Disease Research

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on October 31, 2024 by benzinga